CoreCap Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.6K | Sell |
409
-90
| -18% | -$6.29K | ﹤0.01% | 1471 |
|
|
2025
Q1 | $36.7K | Sell |
499
-143
| -22% | -$10.5K | ﹤0.01% | 1300 |
|
|
2024
Q4 | $42.1K | Buy |
642
+155
| +32% | +$10.2K | ﹤0.01% | 1262 |
|
|
2024
Q3 | $37.9K | Buy |
+487
| New | +$37.9K | ﹤0.01% | 1311 |
|
|
2024
Q2 | – | Sell |
-404
| Closed | -$27.4K | – | 1684 |
|
|
2024
Q1 | $27.4K | Buy |
+404
| New | +$27.4K | ﹤0.01% | 1345 |
|
|
2022
Q4 | $52.8K | Buy |
+778
| New | +$52.8K | ﹤0.01% | 969 |
|
|
2022
Q3 | – | Sell |
-494
| Closed | -$33K | – | 657 |
|
|
2022
Q2 | $33K | Sell |
494
-3,430
| -87% | -$229K | ﹤0.01% | 1076 |
|
|
2022
Q1 | $260K | Sell |
3,924
-109
| -3% | -$7.22K | 0.02% | 439 |
|
|
2021
Q4 | $235K | Buy |
+4,033
| New | +$235K | 0.02% | 500 |
|